Schizophrenia
Overview
- Characterized by
disordered thinking, delusions, hallucinations, depersonalization (feeling
of being strange, not oneself), impaired reality testing (psychosis), and
impaired interpersonal relationships.
- Regression to the
earliest stages of development is often noted (e.g., incontinence, mutism)
- Onset is usually in
adolescence/early adulthood (15-35 years of age).
- Client may be
seriously impaired and unable to perform ADL.
- Etiology is not known;
theories include
1. Genetic: 1% of population
2. Biochemical: neurotransmitter of dysfunction i.e.
dopamine, serotonin
3. Interaction of predisposing risk and environmental
stress.
- Prior to onset
(premorbid) client may have been suspicious, eccentric, or withdrawn.
Classifications
- Disorganized:
Incoherent; delusions are not organized; social withdrawal; affect
blunted, silly, or inappropriate
- Catatonic: psychomotor
disturbances
1. Strupor: mute, little reaction or movement
2. Excitement: purposeless, excited motor activity
3. posturing: voluntary, inappropriate, bizarre postures
- Paranoid: delusions
and hallucinations of persecution/grandeur
- Undifferentiated:
disorganized behaviors, delusions, and hallucinations
Assessment:
- Four A’s
1. Affect: flat, blunted
2. Associative looseness: verbalizations are disorganized
3. Ambivalence: cannot choose between conflicting
emotions
4. Autistic thinking: thoughts on self, extreme
withdrawal, unable to relate to outside world
- Any changes in
thoughts, speech, affect
- Ability to perform
self-care activities, nutritional deficits
- Suicide potential
- Aggression
- Regression
- Impaired communication
Analysis
Nursing diagnosis for clients
with schizophrenic disorders may include:
- anxiety
- impaired verbal
communication
- ineffective
individual/family coping
- high risk for injury
- altered nutrition
- powerlessness
- self-care deficit
- self-esteem
disturbance
- sensory-perceptual
alteration
- sleep pattern
disturbance
- social isolation
- high risk for violence
Planning and Implementation
Goals
Client will:
- develop a
trusting/therapeutic relationship with nurse
- be oriented, able to
test reality
- be protected from
injury
- be able to recognize
impending loss of control
- adhere to medication
regimen
- participate in
activities
- increase ability to
care for self
Interventions
- offer self in
development of therapeutic relationship
- use silence
- set time for
interaction with client
- encourage reality
orientation but understand that delusions/hallucinations are real to
client.
- Assist with
feeding/dressing as necessary
- Check on client
frequently; remove potentially harmful objects
- Contract with client
to tell you when anxiety is becoming so high that loss of control is
possible
- Administer
antipsychotic medications as ordered; observe for effects
1. reduction of hallucinations, delusions, agitation
2. postural hypotension
a. obtain baseline BP and monitor sitting/standing
b. client must lie prone for 1hour following injection
c.
teach client to
sit up or stand up slowly
d. elevate client’s leg while seated
e. withhold drug if
systolic pressure drops more than 20-30mmhg from previous
reading
3. photosensitivity
a. add use of sunscreen
b. avoid exposure to sunlight
4. agranulocytosis
a. instruct client to report sore throat or fever
b. institute reverse isolation if necessary
5. elimination
a. measure I&O
b. check bladder distention
c.
keep bowel record
6. Sedation
a. avoid use of heavy machinery
b. do not drive
7. Extrapyramidal symptoms
a. Dysthonic reactions
i.
Sudden
contractions of face, tongue, extraoccular muscles
ii.
Administer
antiparkinson agents prn (e.g., benztropine (cogentin) 1-8mg or dipenhydramine
(benadryl) 10-50mg), which can be given PO or IM for faster relief;
trihexyphendil (artane) 3-15mg PO only, can also be used prn).
iii.
Remain with
client; this is a frightening experience and usually occurs when medication is
started
b. Parkinson syndrome
i.
Occurs within 1-3
weeks
ii.
Tremors, rigid,
posture, masklike facial appearance
iii.
Administer
antiparkinson agents prn
c.
Akathisia
i.
Motor
restlessness
ii.
Need to keep
moving
iii.
Administer
antiparkinson agents
iv.
Do not mistake
this for agitation; do not increase antipsychotic medication
v.
Reduce
medications to see if symptoms decrease
vi.
Determine if
movement is under voluntary control
d. Tardive dyskinesia
i.
Irreversible
involuntary movements of tongue, face, extremities
ii.
May occur after
prolonged use of antipsychotics
e.
Neuroleptic
malignant syndrome
i.
Occurs days/weeks
after initiation of treatment in 1% of clients
ii.
Elevated VS,
rigidity, and confusion followed by incontinence, mutism, opisthotonos,
retrocollis, renal failure, coma, and death
iii.
Discontinue
medication, notify physician, monitor VS, electrolyte balance, I&O
iv.
Elderly clients
should receive doses reduced by one-half
to one-third of recommended level
8. encourage participation in milieu, group, art, and
occupational therapies when client able to tolerate them.